Egide: 2022 Half year results

Bollène (France), October 25, 2022 – 07 :00 am (CET)
Press Release

2022 Half year results

• H1 2022 sales at €16.02m: – 3.5% YoY, Egide SA (+4.5%) and Santier (+4.9%) sales do not fully compensate for the decrease in Egide USA sales (-20.5%)
• Consolidated operating income: – €1.294 million, affected by recruitment and supply difficulties in the United States
• Net income: – €2.016 million, the losses of the American entities not being offset by the capital gain on the sale of the Cambridge building in IFRS treatment in the consolidation.
• Outlook:
  • The Group expects an improvement in the second half of 2022.
  • Some promising commercial negotiations are underway both in France and the USA.
  • Difficulties related to price increases, in particular for energy and chemical products, are anticipated, with consequent negotiation of sales price increases.

The Audit Committee and the Board of Directors met to approve the half-year financial results as of June 30, 2022. As a reminder, on Euronext Growth, the half-year financial statements are not submitted to an audit by the statutory auditors (Euronext Growth Rules, art. 4.2.1). The financial statements presented below are not and will not be audited.

The Egide Group’s consolidated EBITDA (adjusted from IFRS16) for the six months ended June 30, 2022, amounts to €1.87 million.

*Ebitda corrected from IFRS16

CONSOLIDATED FINANCIALS AS OF JUNE 30, 2022

The Egide group’s consolidated revenues for the first half of 2022 were €16.02 million, down 3.5% compared with the first half of 2021, despite a 4.5% increase in sales at Egide SA and a 4.9% increase at Santier, which did not fully offset the 20.5% decrease in sales at Egide USA, which was favorably impacted by an exchange rate effect, since…